Brief: Zynerba Pharmaceuticals Inc Files For Mixed Shelf Of Up To $300 Million – SEC Filing
16/05/2022 13:26
May 16 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS INC FILES FOR MIXED SHELF OF UP TO
$300
MILLION – SEC FILING
* ZYNERBA PHARMACEUTICALS - SALES AGREEMENT PROSPECTUS
COVERS
OFFERING OF UP TO $75 MILLION OF COMMON STOCK THAT MAY BE ISSUED
UNDER SALES AGREEMENT
Further company coverage: ZYNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary